Objectives: This study aimed to estimate the prevalence of diabetic retinopathy (DR) and its determinant risk factors in people with diabetes attending primary care centers and to determine the impact of expanding the screening interval on the incidence and progression of (DR).
Methodology:This study was a cross-sectional chart review, that was conducted in three randomly selected primary care centers. A total of 250 diabetic patients had three consecutive annual screenings for DR from April 2014 to April 2017. At the initial visit, the ophthalmological findings were recorded. For three successive yearly screening , the screening results were assessed to estimate the changes that occurred in the prevalence, incidence, and progression of diabetic retinopathy in addition to the degree of association with the most predictable risk factors.Results:The initial prevalence of DR was 15.2%. Over the three-consecutive annual screening, the DR prevalence increased to 19.6%, 22.4%, and 25.6%, respectively. Most cases (72%) of DR were of the mild non-proliferative diabetic retinopathy (NPDR) type. The annual incidence of DR was 4.4%, 2.8%, and 3.2%. The progression of DR occurred in 2 (0.08%) cases at the second screening interval and in 6 (2.4%) cases at the third screening interval. These changes were strongly associated with age, the duration of diabetes, HBA1C levels, hypertension, and insulin therapy (P-value 0.005). However, changes in the incidence and progression of DR over the three intervals were statistically non-significant (P-value 0.086).Conclusion: DR, a serious microvascular complication of diabetes mellitus, is an asymptomatic disease with a slow onset and gradual progression. DR requires regular screening for early detection. The screening interval can be extended up to every three years in the very low-risk groups without threatening vision.